Chimerix, Inc. (CMRX) Covered Calls
Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.
There are no covered calls available for Chimerix, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to address unmet medical need. Its proprietary lipid technology to unlock the potential of some of the most broad-spectrum antivirals by enhancing their antiviral activity and safety profiles in convenient, orally administered dosing regiments. The company has two nucleotide compounds in clinical development that utilize their proprietary lipid technology. Brincidofovir and CMX157. Chimerix was founded by George R. Painter and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
| Top 10 Open Interest For May 16 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | GLD covered calls | 1. | ZETA covered calls | |
| 2. | SPY covered calls | 7. | IWM covered calls | 2. | ENVX covered calls | |
| 3. | TLT covered calls | 8. | FXI covered calls | 3. | HLF covered calls | |
| 4. | SLV covered calls | 9. | SNAP covered calls | 4. | QCOM covered calls | |
| 5. | QQQ covered calls | 10. | TSLA covered calls | 5. | RDDT covered calls | |
Want more examples? CMRE Covered Calls | CMS Covered Calls
